Bibliography

Export 24 results:

Filters: Keyword is Time Factors and Author is Penn,I. [Clear All Filters]

1997

Penn I. Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant. 1997;2(4):14-7.

1995

Penn I, Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation. 1995;59(2):240-4.

1993

Penn I. Effect of immunosuppression on preexisting cancers. Transplant Proc. 1993;25(1 Pt 2):1380-2.

Penn I. Kidney transplantation in patients previously treated for renal carcinomas. Transpl Int. 1993;6(6):350.

Penn I. Neoplastic complications of transplantation. Semin Respir Infect. 1993;8(3):233-9.

1989

Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients. Am J Kidney Dis. 1989;14(5 Suppl 2):14-8.

First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, et al. Successful retreatment of allograft rejection with OKT3. Transplantation. 1989;47(1):88-91.

1986

Penn I, First MR. Development and incidence of cancer following cyclosporine therapy. Transplant Proc. 1986;18(2 Suppl 1):210-5.

1981

Penn I. Malignant lymphomas in organ transplant recipients. Transplant Proc. 1981;13(1 Pt 2):736-8.

1979

Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation. 1979;27(1):8-11.

Penn I. Leukemias and lymphomas associated with the use of cytotoxic and immunosuppressive drugs. Recent Results Cancer Res. 1979;69:7-13.

1978

Penn I. Risk of lymphoma after cardiac transplantation. Lancet. 1978;2(8104-5):1385.

1977

Penn I. Development of cancer as a complication of clinical transplantation. Transplant Proc. 1977;9(1):1121-7.

Penn I. Malignancies associated with renal transplantation. Urology. 1977;10(1 Suppl):57-63.

Penn I. Transplantation in patients with primary renal malignancies. Transplantation. 1977;24(6):424-34.

1974

Koranda FC, Dehmel EM, Kahn G, Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. Jama. 1974;229(4):419-24.

1973

Gustafsson A, Groth CG, Halgrimson CG, Penn I, Starzl TE. The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet. 1973;137(1):40-2.

1972

Andres GA, Ansell ID, Halgrimson CG, Hsu KC, Porter KA, Starzl TE, et al. Immunopathological studies of orthotopic human liver allografts. Lancet. 1972;1(7745):275-80.

1971

Starzl TE, Halgrimson CG, Penn I, Martineau G, Schroter G, Amemiya H, et al. Cyclophosphamide and human organ transplantation. Lancet. 1971;2(7715):70-4.

Starzl TE, Putnam CW, Halgrimson CG, Schroter GT, Martineau G, Launois B, et al. Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet. 1971;133(6):981-91.

Schneck SA, Penn I. De-novo brain tumours in renal-transplant recipients. Lancet. 1971;1(7707):983-6.

Halgrimson CG, Rapaport FT, Terasaki PI, Porter KA, Andres G, Penn I, et al. Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc. 1971;3(1):140-4.

Penn I, Makowski E, Droegemueller W, Halgrimson CG, Starzl TE. Parenthood in renal homograft recipients. Jama. 1971;216(11):1755-61.

1970

Coburg AJ, Gray SH, Katz FH, Penn I, Halgrimson C, Starzl TE. Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. Surg Gynecol Obstet. 1970;131(5):933-42.